{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T05:34:57Z","timestamp":1782538497529,"version":"3.54.5"},"reference-count":61,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019274","name":"National Institute of Mental Health and Neurosciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01 NS125271"],"award-info":[{"award-number":["R01 NS125271"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["U19NS107616"],"award-info":[{"award-number":["U19NS107616"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014370","name":"Simons Foundation Autism Research Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014370","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01 MH071739"],"award-info":[{"award-number":["R01 MH071739"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01 NS110869"],"award-info":[{"award-number":["R01 NS110869"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R25 NS065745"],"award-info":[{"award-number":["R25 NS065745"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007321","name":"Finding A Cure for Epilepsy and Seizures","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007321","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.molpha.2025.100017","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T18:54:12Z","timestamp":1738954452000},"page":"100017","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Ion channels and G protein-coupled receptors: Cannabidiol actions on disorders of excitability and synaptic excitatory-inhibitory ratio"],"prefix":"10.1016","volume":"107","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7428-9722","authenticated-orcid":false,"given":"Richard W.","family":"Tsien","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9846-1507","authenticated-orcid":false,"given":"Evan C.","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molpha.2025.100017_bib1","doi-asserted-by":"crossref","first-page":"7895","DOI":"10.1073\/pnas.0511232103","article-title":"Inhibition of an equilibrative nucleoside transporter by cannabidiol: A mechanism of cannabinoid immunosuppression","volume":"103","author":"Carrier","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.molpha.2025.100017_bib2","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1146\/annurev-pharmtox-011112-140232","article-title":"Sodium channels, inherited epilepsy, and antiepileptic drugs","volume":"54","author":"Catterall","year":"2014","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.molpha.2025.100017_bib3","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1007\/s11064-017-2314-9","article-title":"Forty years of sodium channels: Structure, function, pharmacology, and epilepsy","volume":"42","author":"Catterall","year":"2017","journal-title":"Neurochem Res"},{"issue":"Pt 11","key":"10.1016\/j.molpha.2025.100017_bib4","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1113\/jphysiol.2010.187484","article-title":"NaV1.1 channels and epilepsy","volume":"588","author":"Catterall","year":"2010","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.molpha.2025.100017_bib5","doi-asserted-by":"crossref","first-page":"14646","DOI":"10.1073\/pnas.1211591109","article-title":"Specific deletion of NaV1.1 sodium channels in inhibitory interneurons causes seizures and premature death in a mouse model of Dravet syndrome","volume":"109","author":"Cheah","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.molpha.2025.100017_bib6","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1126\/science.aad0314","article-title":"The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring","volume":"351","author":"Choi","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.molpha.2025.100017_bib7","first-page":"81","article-title":"Combined antiseizure efficacy of cannabidiol and clonazepam in a conditional mouse model of Dravet syndrome","volume":"2","author":"Chuang","year":"2021","journal-title":"J\u00a0Exp Neurol"},{"key":"10.1016\/j.molpha.2025.100017_bib8","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1086\/320609","article-title":"De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy","volume":"68","author":"Claes","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.molpha.2025.100017_bib9","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/epi.17444","article-title":"SCN1A gain-of-function mutation causing an early onset epileptic encephalopathy","volume":"64","author":"Clatot","year":"2023","journal-title":"Epilepsia"},{"key":"10.1016\/j.molpha.2025.100017_bib10","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/sj.bjp.0705920","article-title":"Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation","volume":"143","author":"Costa","year":"2004","journal-title":"Bri J Pharmacol"},{"key":"10.1016\/j.molpha.2025.100017_bib11","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1111\/j.1476-5381.2010.01166.x","article-title":"Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes","volume":"163","author":"De Petrocellis","year":"2011","journal-title":"Bri J Pharmacol"},{"key":"10.1016\/j.molpha.2025.100017_bib12","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1056\/NEJMoa1611618","article-title":"Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome","volume":"376","author":"Devinsky","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.molpha.2025.100017_bib13","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1152\/physrev.00049.2021","article-title":"Cannabinoid treatments in epilepsy and seizure disorders","volume":"104","author":"Devinsky","year":"2024","journal-title":"Physiol Rev"},{"issue":"Suppl 2","key":"10.1016\/j.molpha.2025.100017_bib14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1528-1167.2011.02994.x","article-title":"The core Dravet syndrome phenotype","volume":"52","author":"Dravet","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.molpha.2025.100017_bib15","doi-asserted-by":"crossref","first-page":"7912","DOI":"10.1523\/JNEUROSCI.0193-18.2018","article-title":"A\u00a0transient developmental window of Fast-Spiking interneuron dysfunction in a mouse model of Dravet syndrome","volume":"38","author":"Favero","year":"2018","journal-title":"The J Neurosci"},{"key":"10.1016\/j.molpha.2025.100017_bib16","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1146\/annurev-neuro-071714-034002","article-title":"Plasticity of cortical excitatory-inhibitory balance","volume":"38","author":"Froemke","year":"2015","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.molpha.2025.100017_bib17","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1111\/epi.13852","article-title":"Interactions between cannabidiol and commonly used antiepileptic drugs","volume":"58","author":"Gaston","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.molpha.2025.100017_bib18","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1111\/epi.13060","article-title":"Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy","volume":"56","author":"Geffrey","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.molpha.2025.100017_bib19","doi-asserted-by":"crossref","first-page":"16546","DOI":"10.1074\/jbc.RA118.004929","article-title":"Inhibitory effects of cannabidiol on voltage-dependent sodium currents","volume":"293","author":"Ghovanloo","year":"2018","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.molpha.2025.100017_bib20","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.46846","article-title":"Vasoactive intestinal peptide-expressing interneurons are impaired in a mouse model of Dravet syndrome","volume":"8","author":"Goff","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.molpha.2025.100017_bib21","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1089\/can.2019.0028","article-title":"Anticonvulsive properties of cannabidiol in a model of generalized seizure are transient receptor potential Vanilloid 1 dependent","volume":"5","author":"Gray","year":"2020","journal-title":"Cannabis Cannabinoid Res"},{"key":"10.1016\/j.molpha.2025.100017_bib22","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nature11356","article-title":"Autistic-like behaviour in Scn1a+\/- mice and rescue by enhanced GABA-mediated neurotransmission","volume":"489","author":"Han","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.molpha.2025.100017_bib23","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1096\/fj.08-108670","article-title":"The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation","volume":"23","author":"Henstridge","year":"2009","journal-title":"FASEB J"},{"key":"10.1016\/j.molpha.2025.100017_bib24","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1038\/s41467-023-39307-6","article-title":"Cannabidiol inhibits Na(v) channels through two distinct binding sites","volume":"14","author":"Huang","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.molpha.2025.100017_bib25","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/s41580-024-00763-7","article-title":"Structural biology and molecular pharmacology of voltage-gated ion channels","volume":"25","author":"Huang","year":"2024","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.molpha.2025.100017_bib26","series-title":"Eye, brain, and vision","author":"Hubel","year":"1995"},{"key":"10.1016\/j.molpha.2025.100017_bib27","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s13311-015-0377-3","article-title":"Molecular targets of cannabidiol in neurological disorders","volume":"12","author":"Ibeas Bih","year":"2015","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.molpha.2025.100017_bib28","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.ajhg.2016.07.019","article-title":"Mutations in MBOAT7, encoding lysophosphatidylinositol acyltransferase I, lead to intellectual disability accompanied by epilepsy and autistic features","volume":"99","author":"Johansen","year":"2016","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.molpha.2025.100017_bib29","doi-asserted-by":"crossref","first-page":"11065","DOI":"10.1523\/JNEUROSCI.2162-07.2007","article-title":"Reduced sodium current in Purkinje neurons from Nav1.1 mutant mice: Implications for ataxia in severe myoclonic epilepsy in infancy","volume":"27","author":"Kalume","year":"2007","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.molpha.2025.100017_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110580","article-title":"Developmentally regulated impairment of parvalbumin interneuron synaptic transmission in an experimental model of Dravet syndrome","volume":"38","author":"Kaneko","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.molpha.2025.100017_bib31","doi-asserted-by":"crossref","first-page":"11229","DOI":"10.1073\/pnas.1711351114","article-title":"Cannabidiol attenuates seizures and social deficits in a mouse model of Dravet syndrome","volume":"114","author":"Kaplan","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.molpha.2025.100017_bib32","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1111\/bph.14202","article-title":"Cannabidiol exerts antiepileptic effects by restoring hippocampal interneuron functions in a temporal lobe epilepsy model","volume":"175","author":"Khan","year":"2018","journal-title":"Bri J Pharmacol"},{"key":"10.1016\/j.molpha.2025.100017_bib33","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1111\/bph.13250","article-title":"Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor","volume":"172","author":"Laprairie","year":"2015","journal-title":"Bri J Pharmacol"},{"key":"10.1016\/j.molpha.2025.100017_bib34","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1073\/pnas.0711278105","article-title":"GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current","volume":"105","author":"Lauckner","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.molpha.2025.100017_bib35","doi-asserted-by":"crossref","first-page":"4689","DOI":"10.1091\/mbc.e12-09-0673","article-title":"LPIAT1 regulates arachidonic acid content in phosphatidylinositol and is required for cortical lamination in mice","volume":"23","author":"Lee","year":"2012","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.molpha.2025.100017_bib36","article-title":"Ndnf interneuron excitability is spared in a mouse model of Dravet syndrome","volume":"44","author":"Liebergall","year":"2024","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.molpha.2025.100017_bib37","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/ana.23897","article-title":"Dravet syndrome patient-derived neurons suggest a novel epilepsy mechanism","volume":"74","author":"Liu","year":"2013","journal-title":"Ann Neurol"},{"key":"10.1016\/j.molpha.2025.100017_bib38","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.neuron.2016.02.017","article-title":"Unifying views of autism spectrum disorders: A consideration of autoregulatory feedback loops","volume":"89","author":"Mullins","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.molpha.2025.100017_bib39","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.bbrc.2007.08.078","article-title":"Identification of GPR55 as a lysophosphatidylinositol receptor","volume":"362","author":"Oka","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"issue":"Pt 8","key":"10.1016\/j.molpha.2025.100017_bib40","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1093\/brain\/aww129","article-title":"Aberrant epilepsy-associated mutant Nav1.6 sodium channel activity can be targeted with cannabidiol","volume":"139","author":"Patel","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.molpha.2025.100017_bib41","doi-asserted-by":"crossref","first-page":"10764","DOI":"10.1523\/JNEUROSCI.2475-09.2009","article-title":"A\u00a0functional null mutation of SCN1B in a patient with Dravet syndrome","volume":"29","author":"Patino","year":"2009","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.molpha.2025.100017_bib42","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.yebeh.2017.04.045","article-title":"Assessing the role of serotonergic receptors in cannabidiol's anticonvulsant efficacy","volume":"73","author":"Pelz","year":"2017","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.molpha.2025.100017_bib43","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.bbalip.2012.01.009","article-title":"Lysophosphatidylinositol signalling: New wine from an old bottle","volume":"1821","author":"Pineiro","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.molpha.2025.100017_bib44","doi-asserted-by":"crossref","first-page":"e949","DOI":"10.1038\/cddis.2013.471","article-title":"Direct modulation of the outer mitochondrial membrane channel, voltage-dependent anion channel 1 (VDAC1) by cannabidiol: A novel mechanism for cannabinoid-induced cell death","volume":"4","author":"Rimmerman","year":"2013","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.molpha.2025.100017_bib45","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.neuron.2023.01.018","article-title":"Cannabidiol modulates excitatory-inhibitory ratio to counter hippocampal hyperactivity","volume":"111","author":"Rosenberg","year":"2023","journal-title":"Neuron"},{"key":"10.1016\/j.molpha.2025.100017_bib46","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.tips.2008.12.004","article-title":"The enigmatic pharmacology of GPR55","volume":"30","author":"Ross","year":"2009","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.molpha.2025.100017_bib47","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s11064-005-6978-1","article-title":"Agonistic properties of cannabidiol at 5-HT1a receptors","volume":"30","author":"Russo","year":"2005","journal-title":"Neurochem Res"},{"key":"10.1016\/j.molpha.2025.100017_bib48","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/sj.bjp.0707460","article-title":"The orphan receptor GPR55 is a novel cannabinoid receptor","volume":"152","author":"Ryberg","year":"2007","journal-title":"Bri J Pharmacol"},{"key":"10.1016\/j.molpha.2025.100017_bib49","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3389\/fphar.2015.00069","article-title":"The therapeutic potential of orphan GPCRs, GPR35 and GPR55","volume":"6","author":"Shore","year":"2015","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.molpha.2025.100017_bib50","doi-asserted-by":"crossref","first-page":"16571","DOI":"10.1073\/pnas.1906833116","article-title":"Hippocampal deletion of Na(V)1.1 channels in mice causes thermal seizures and cognitive deficit characteristic of Dravet syndrome","volume":"116","author":"Stein","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.molpha.2025.100017_bib51","doi-asserted-by":"crossref","first-page":"5224","DOI":"10.1091\/mbc.e09-05-0382","article-title":"Drosophila lysophospholipid acyltransferases are specifically required for germ cell development","volume":"20","author":"Steinhauer","year":"2009","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.molpha.2025.100017_bib52","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1124\/mol.118.111864","article-title":"Cannabidiol inhibits endocannabinoid signaling in autaptic hippocampal neurons","volume":"94","author":"Straiker","year":"2018","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.molpha.2025.100017_bib53","doi-asserted-by":"crossref","first-page":"5193","DOI":"10.1073\/pnas.1211204110","article-title":"Cannabinoid- and lysophosphatidylinositol-sensitive receptor GPR55 boosts neurotransmitter release at central synapses","volume":"110","author":"Sylantyev","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.molpha.2025.100017_bib54","doi-asserted-by":"crossref","first-page":"E3139","DOI":"10.1073\/pnas.1411131111","article-title":"Impaired excitability of somatostatin- and parvalbumin-expressing cortical interneurons in a mouse model of Dravet syndrome","volume":"111","author":"Tai","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.molpha.2025.100017_bib55","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1126\/science.2458625","article-title":"Identification of an intracellular peptide segment involved in sodium channel inactivation","volume":"241","author":"Vassilev","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.molpha.2025.100017_bib56","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nature02116","article-title":"Balanced inhibition underlies tuning and sharpens spike timing in auditory cortex","volume":"426","author":"Wehr","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.molpha.2025.100017_bib57","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.prostaglandins.2013.05.004","article-title":"The actions and metabolism of lysophosphatidylinositol, an endogenous agonist for GPR55","volume":"107","author":"Yamashita","year":"2013","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1016\/j.molpha.2025.100017_bib58","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.cell.2017.06.039","article-title":"Structure of the Na(v)1.4\u2013beta1 complex from Electric Eel","volume":"170","author":"Yan","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.molpha.2025.100017_bib59","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/nn1754","article-title":"Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy","volume":"9","author":"Yu","year":"2006","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.molpha.2025.100017_bib60","doi-asserted-by":"crossref","first-page":"6371","DOI":"10.1523\/JNEUROSCI.3216-20.2021","article-title":"Cannabidiol inhibition of murine primary nociceptors: Tight binding to slow inactivated states of Na(v)1.8 channels","volume":"41","author":"Zhang","year":"2021","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.molpha.2025.100017_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109715","article-title":"Restoring prefrontal cortical excitation-inhibition balance with cannabidiol ameliorates neurobehavioral abnormalities in a mouse model of neurodevelopmental disorders","volume":"240","author":"Zhang","year":"2023","journal-title":"Neuropharmacology"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X25000033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X25000033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:39:10Z","timestamp":1777394350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X25000033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":61,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0026895X25000033"],"URL":"https:\/\/doi.org\/10.1016\/j.molpha.2025.100017","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ion channels and G protein-coupled receptors: Cannabidiol actions on disorders of excitability and synaptic excitatory-inhibitory ratio","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molpha.2025.100017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"100017"}}